ag 1879 has been researched along with paclitaxel in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, T; Pengetnze, Y; Taylor, CC | 1 |
Bedalov, CO; Prosperi, JR; Soto, KF; VanKlompenberg, MK | 1 |
Adachi, J; Horiuchi, M; Kuga, T; Nagano, M; Nakayama, Y; Saito, Y; Tomonaga, T; Yamaguchi, N | 1 |
3 other study(ies) available for ag 1879 and paclitaxel
Article | Year |
---|---|
Src inhibition enhances paclitaxel cytotoxicity in ovarian cancer cells by caspase-9-independent activation of caspase-3.
Topics: Animals; Antineoplastic Agents, Phytogenic; Caspase 3; Caspase 9; Caspases; Cisplatin; Cytochromes c; Drug Resistance, Neoplasm; Enzyme Activation; Female; Humans; Mice; Ovarian Neoplasms; Paclitaxel; Protein Kinase Inhibitors; Pyrimidines; src-Family Kinases; Tumor Cells, Cultured | 2005 |
APC selectively mediates response to chemotherapeutic agents in breast cancer.
Topics: Adenomatous Polyposis Coli Protein; Animals; Anthracenes; Apoptosis; Breast Neoplasms; Carcinogenesis; Cell Proliferation; Cisplatin; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Kinase 4; Mice; Mice, Transgenic; Paclitaxel; Pyrimidines; src-Family Kinases | 2015 |
The tyrosine kinase v-Src causes mitotic slippage by phosphorylating an inhibitory tyrosine residue of Cdk1.
Topics: Antineoplastic Agents, Phytogenic; CDC2 Protein Kinase; Cell Proliferation; HeLa Cells; Humans; Microtubules; Mitosis; Oncogene Protein pp60(v-src); Paclitaxel; Phosphoproteins; Phosphorylation; Polyploidy; Protein Kinase Inhibitors; Pyrimidines; RNA, Small Interfering; Time-Lapse Imaging | 2018 |